Cargando…

The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

SIMPLE SUMMARY: The aim of this study was to assess the prevalence and characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain. This prospective study showed that in this population, BTcP prevalence was 69.8%. Many patients did not achieve a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mercadante, Sebastiano, Maltoni, Marco, Russo, Domenico, Adile, Claudio, Ferrera, Patrizia, Rossi, Romina, Rosati, Marta, Casuccio, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958843/ https://www.ncbi.nlm.nih.gov/pubmed/33801478 http://dx.doi.org/10.3390/cancers13051058

Ejemplares similares

Methadone as First-line Opioid for the Management of Cancer Pain
por: Mercadante, Sebastiano, et al.
Publicado: (2022)

Episodic Breathlessness with and without Background Dyspnea in Advanced Cancer Patients Admitted to an Acute Supportive Care Unit
por: Mercadante, Sebastiano, et al.
Publicado: (2020)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients’ Oncological Pathway
por: Mercadante, Sebastiano, et al.
Publicado: (2016)

Once again... breakthrough cancer pain: an updated overview
por: Mercadante, Sebastiano
Publicado: (2023)

Palliative Care in the Time of COVID-19
por: Mercadante, Sebastiano, et al.
Publicado: (2020)

The Use of Parenteral Opioids in Cancer Pain Management
por: Mercadante, Sebastiano
Publicado: (2023)

A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study
por: Mercadante, Sebastiano, et al.
Publicado: (2021)

Breakthrough Pain: The Importance of Baseline Analgesic Regimen with Opioids
por: Zampi, Maddalena, et al.
Publicado: (2012)

Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management
por: Mercadante, Sebastiano
Publicado: (2019)

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study
por: Mercadante, Sebastiano, et al.
Publicado: (2020)

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Smith, Howard S
Publicado: (2013)

A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain
por: Smith, Howard
Publicado: (2012)

Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Perelman, Michael, et al.
Publicado: (2013)

Risk of detrimental recommendations for cancer pain management
por: Maltoni, Marco, et al.
Publicado: (2021)

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
por: Pantano, Francesco, et al.
Publicado: (2020)

Opioid combination for cancer pain
por: Mercadante, S
Publicado: (2004)

Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study
por: Mazzotta, Marco, et al.
Publicado: (2022)

Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain
por: Devulder, J., et al.
Publicado: (2009)

Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment – case series and review of the literature
por: Batistaki, Chrysanthi, et al.
Publicado: (2022)

Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice
por: Bossi, Paolo, et al.
Publicado: (2022)

Assessment and treatment of breakthrough cancer pain: from theory to clinical practice
por: Vellucci, Renato, et al.
Publicado: (2017)

Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study
por: Yen, Tsung-Yu, et al.
Publicado: (2018)

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
por: Cuomo, Arturo, et al.
Publicado: (2020)

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
por: Mercadante, Sebastiano, et al.
Publicado: (2016)

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018)

Pain and recovery following cesarean delivery in patients receiving an opioid-sparing pain regimen
por: Peahl, Alex F., et al.
Publicado: (2023)

Management of breakthrough pain in children with cancer
por: Friedrichsdorf, Stefan J, et al.
Publicado: (2014)

Management of breakthrough pain due to cancer
por: Rudowska, Joanna
Publicado: (2013)

Breakthrough pain in patients with controlled or uncontrolled pain: An observational study
por: Gatti, Antonio, et al.
Publicado: (2014)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor, Donald R
Publicado: (2013)

Opioids for acute and chronic pain when receiving psychiatric medications
por: Janakiram, Chandrashekar, et al.
Publicado: (2023)

The effect of transdermal opioid use on breakthrough opioid and sedative prescribing for rural patients with chronic pain in Northwest Tasmania: a longitudinal study
por: Henshaw, John, et al.
Publicado: (2013)

The Patient with Difficult Cancer Pain
por: Mercadante, Sebastiano
Publicado: (2019)

Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study
por: Cascella, Marco, et al.
Publicado: (2021)

Timely Palliative Care Could Be Another Benefit for Cancer Patients with Non-Malignant Pain
por: Maltoni, Marco C., et al.
Publicado: (2023)

Breakthrough cancer pain – still a challenge
por: Margarit, Cesar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7aa204n6ankm3n0kushljf9dk9